相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence of Incidental Pancreatic Cysts in the Adult Population on MR Imaging
Karen S. Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment
Yixing Jiang et al.
BIOMARKERS IN MEDICINE (2010)
Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future
Shayna L. Showalter et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group-Directed Intergroup Trial S0205
Philip A. Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Ruth Halaban et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature
Edward James et al.
ANTI-CANCER DRUGS (2009)
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Fay Kastrinos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li et al.
NATURE BIOTECHNOLOGY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Prevalence of unsuspected pancreatic cysts on MDCT
Thomas A. Laffan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
Neil P. Desai et al.
ANTI-CANCER DRUGS (2008)
A syngeneic variance library for functional annotation of human variation:: Application to BRCA2
Tomas Hucl et al.
CANCER RESEARCH (2008)
Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer
Jordan M. Winter et al.
CLINICAL CANCER RESEARCH (2008)
DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease
Mansour A. Parsi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II
Alejandro D. Treszezamsky et al.
CANCER RESEARCH (2007)
Distinguishing rational from irrational applications of pharmacogenetic synergies from the bench to clinical trials
Tomas Hucl et al.
CELL CYCLE (2007)
Chinese hamster cell mutant, V-C8, a model for analysis of Brca2 function
Wouter W. Wiegant et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas
Eunice L. Kwak et al.
CLINICAL CANCER RESEARCH (2006)
PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas
Frank Schoenleben et al.
CLINICAL CANCER RESEARCH (2006)
Screening for early pancreatic neoplasia in high-risk individuals: A prospective controlled study
Marcia Irene Canto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options
Eike Gallmeier et al.
GASTROENTEROLOGY (2006)
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: Relationship to molecular mechanisms of gemcitabine resistance and survival
V Sebastiani et al.
CLINICAL CANCER RESEARCH (2006)
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
C Hunter et al.
CANCER RESEARCH (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies
DW Nyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
JM Carethers et al.
GASTROENTEROLOGY (2004)
Mesothelin-specific CD8+ T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients
AM Thomas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma
J Spratlin et al.
CLINICAL CANCER RESEARCH (2004)
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu
H Safran et al.
CANCER INVESTIGATION (2004)
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
DM Berman et al.
NATURE (2003)
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions
N Sato et al.
ONCOGENE (2003)
Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms
F Sahin et al.
MODERN PATHOLOGY (2003)
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignancies
E Montgomery et al.
CANCER BIOLOGY & THERAPY (2003)
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia
NT van Heek et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Very high risk of cancer in familial Peutz-Jeghers syndrome
FM Giardiello et al.
GASTROENTEROLOGY (2000)
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis
H Witt et al.
NATURE GENETICS (2000)
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas -: A newly described and characterized entity
RE Wilentz et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
